Business Context and Reporting Period
Company: IRIDEX CORPORATION
Filing Type: Form 8-K (Current Report)
Date of Report: August 21, 2006
Reporting Period: The filing addresses a delay in the Form 10-Q for the fiscal quarter ended July 1, 2006, and investigates potential accounting errors in fiscal 2004 and 2005.
Key Financial Metrics
This filing does not report current period revenue, profit, cash flow, or liquidity metrics. It focuses on specific historical revenue recognition errors:
- Disputed Order 1: $64,000 (Delivered Dec 2004, paid Q1 2005).
- Disputed Order 2: $34,000 (Booked Dec 2004, returned Q1 2005).
- Total Impact: $98,000, representing 1.1% of revenue in the fourth quarter of fiscal 2004.
- Historical Return Rates: Less than 1% of total revenues for the 2.5-year period ending July 1, 2006.
Material Changes and Events
The primary material event is the inability to file the Q2 2006 Form 10-Q by the August 15, 2006 deadline due to an ongoing investigation into revenue recognition practices. The Audit Committee, supported by outside counsel, confirmed that:
- Revenue for a $64,000 order was prematurely recognized in Q4 2004.
- Revenue for an additional $34,000 order was inappropriately booked in December 2004.
- The sales representative involved in these orders was no longer an employee as of January 2005.
Outlook, Risks, and Management Commentary
Management Action: The Audit Committee is continuing its review to determine if financial statement restatements are required for Q4 2004 (ended Jan 1, 2005) and Q1 2005 (ended March 31, 2005).
Consequence: The filing of the Q2 2006 Form 10-Q is deferred pending the outcome of this review.
Risks: Potential restatement of historical financials and regulatory scrutiny regarding revenue recognition controls.
Investor Verification Checklist
- Confirm the final determination on whether Q4 2004 and Q1 2005 financial statements require restatement.
- Monitor the timeline for the delayed Q2 2006 Form 10-Q filing.
- Review any subsequent disclosures regarding the scope of the external review and potential impact on other periods.
- Verify if the $98,000 error impacts any other financial covenants or metrics.